Sector portfolio · Corporate investor · United States
MedImmune Ventures' Biotech portfolio
MedImmune Ventures has backed 10 Biotech startups in rounds we track, $1.1B between them, shown by the stage each has reached. The best-funded is Adc Therapeutics.
Funding by segment
- Stage not reported$188M4
- Series C and later$864M4
- Series B$89M2
Where they are based
- United States9$495M
- Switzerland1$646M
United States
SwitzerlandFounded
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M3
- $50M to $250M6
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
10 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States9
- Switzerland1
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
4 startups · $188M raised
- LPLigoCyte PharmaceuticalsLigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications.United States$72M
Virdante PharmaceuticalsVirdante Pharmaceuticals is a biopharmaceutical company developing and commercializing drugs for autoimmune and inflammatory diseases.United States$60M- ATAltiris TherapeuticsAltiris Therapeutics develops and commercializes drugs to treat metastatic cancer.United States$44M
- NTNKT TherapeuticsNKT Therapeutics is a privately held biotechnology company focused on developing therapeutics to treat cancer and other serious diseases.United States$12M
Series C and later
4 startups · $864M raised
ADC TherapeuticsADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.Switzerland$646M
Hydra BiosciencesHydra Biosciences is a biopharmaceutical company based in Cambridge, Massachusetts, founded in 2001.United States$95M
Inotek PharmaceuticalsInotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.United States$70M- ICIomai CorporationIomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology callUnited States$54M
Series B
2 startups · $89M raised
- CCorvidiaCorvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.United States$61M
CoferonCoferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells.United States$28M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names MedImmune Ventures as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like MedImmune Ventures?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.